Phyxius Pharma (Levosimendan Drug) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Phyxius Pharma (Levosimendan Drug) General Information

Description

Levosimendan is a drug to prevent and treat cardiac surgery patients. The drug is currently approved in 53 countries to treat acute decompensated heart failure, a critical heart disease condition.

Contact Information

Website
www.phyxiuspharma.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 14 Green Hill Road
  • Chester, NJ 07930
  • United States
Primary Industry
Buildings and Property
Other Industries
Drug Discovery
Acquirer
Tenax Therapeutics
Vertical(s)
Life Sciences
Corporate Office
  • 14 Green Hill Road
  • Chester, NJ 07930
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Phyxius Pharma (Levosimendan Drug) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Phyxius Pharma (Levosimendan Drug)‘s full profile, request access.

Request a free trial

Phyxius Pharma (Levosimendan Drug) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Phyxius Pharma (Levosimendan Drug)‘s full profile, request access.

Request a free trial

Phyxius Pharma (Levosimendan Drug) FAQs

  • Where is Phyxius Pharma (Levosimendan Drug) headquartered?

    Phyxius Pharma (Levosimendan Drug) is headquartered in Chester, NJ.

  • What industry is Phyxius Pharma (Levosimendan Drug) in?

    Phyxius Pharma (Levosimendan Drug)’s primary industry is Buildings and Property.

  • Is Phyxius Pharma (Levosimendan Drug) a private or public company?

    Phyxius Pharma (Levosimendan Drug) is a Private company.

  • What is the current valuation of Phyxius Pharma (Levosimendan Drug)?

    The current valuation of Phyxius Pharma (Levosimendan Drug) is .

  • What is Phyxius Pharma (Levosimendan Drug)’s current revenue?

    The current revenue for Phyxius Pharma (Levosimendan Drug) is .

  • Who are Phyxius Pharma (Levosimendan Drug)’s investors?

    Phyxius Pharma has invested in Phyxius Pharma (Levosimendan Drug).

  • When was Phyxius Pharma (Levosimendan Drug) acquired?

    Phyxius Pharma (Levosimendan Drug) was acquired on 14-Nov-2013.

  • Who acquired Phyxius Pharma (Levosimendan Drug)?

    Phyxius Pharma (Levosimendan Drug) was acquired by Tenax Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process